OPS
CDNA icon

Orion Portfolio Solutions’s CareDx CDNA Stock Holding History

Orion Portfolio Solutions’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11
Closed – – 1944
2019
Q4 		$0 Buy
+11
New +$252 ﹤0.01% 1821

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Orion Portfolio Solutions's CDNA Position: Q1 2020 in Review

Orion Portfolio Solutions sold out of CareDx (CDNA) in Q1 2020, closing a stake of 11 shares.

Orion Portfolio Solutions first reported a position in CDNA in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.

  • Orion Portfolio Solutions reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 11 CareDx shares in Q1 2020.
  • Orion Portfolio Solutions first reported a position in CareDx in Q4 2019 and held it in 1 quarter.
  • Orion Portfolio Solutions's CareDx position peaked at $0 in Q4 2019.
  • 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.

Based on Orion Portfolio Solutions's 13F filing for Q1 2020, filed 15 May 2020.